1 – 10 of 464
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
- Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
- 2014
- MYCN safeguards its upregulated expression through negatively controlling its upstream miRNAs
- Phf6 plays a role in hematopoiesis and thymopoiesis in zebrafish
- Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma
- Emergence of new ALK mutations at relapse of neuroblastoma
- The H3K27me3 demethylase UTX in normal development and disease
- Integrative analysis of the NOTCH1 regulatory network identifies key downstream lncRNAs in acute T-cell lymphoblastic leukemia and normal T-cell development
- ABT-199 mediated inhibition of BCL2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
- Update: Potential prognostic impact of BTLA/CD200 in Pre-B-ALL
- Prognostic relevance of BTLA/CD200 deletion in pediatric pre-B cell acute lymphoblastic leukemia